Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway

BACKGROUND: Oridonin is the core bioactive component of Rabdosia rubescens, a traditional Chinese herbal medicine used in the treatment of hepatoma. Sorafenib, a targeted therapeutic agent for advanced hepatocellular carcinoma (HCC), has recently been shown to exert limited clinical effects. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xuguang, Chen, Weirun, Liu, Kaihang, Zhang, Sheng, Yang, Ru, Liu, Kairui, Li, Dateng, Huang, Youxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494228/
https://www.ncbi.nlm.nih.gov/pubmed/32982405
http://dx.doi.org/10.2147/CMAR.S257482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494228/
https://www.ncbi.nlm.nih.gov/pubmed/32982405
http://dx.doi.org/10.2147/CMAR.S257482

Ejemplares similares